| Literature DB >> 24204990 |
Carol H Sandt1, Paula J Fedorka-Cray, Deepanker Tewari, Stephen Ostroff, Kevin Joyce, Nkuchia M M'ikanatha.
Abstract
Salmonellosis is one of the most important foodborne diseases affecting humans. To characterize the relationship between Salmonella causing human infections and their food animal reservoirs, we compared pulsed-field gel electrophoresis (PFGE) and antimicrobial susceptibility patterns of non-typhoidal Salmonella isolated from ill humans in Pennsylvania and from food animals before retail. Human clinical isolates were received from 2005 through 2011 during routine public health operations in Pennsylvania. Isolates from cattle, chickens, swine and turkeys were recovered during the same period from federally inspected slaughter and processing facilities in the northeastern United States. We found that subtyping Salmonella isolates by PFGE revealed differences in antimicrobial susceptibility patterns and, for human Salmonella, differences in sources and invasiveness that were not evident from serotyping alone. Sixteen of the 20 most common human Salmonella PFGE patterns were identified in Salmonella recovered from food animals. The most common human Salmonella PFGE pattern, Enteritidis pattern JEGX01.0004 (JEGX01.0003ARS), was associated with more cases of invasive salmonellosis than all other patterns. In food animals, this pattern was almost exclusively (99%) found in Salmonella recovered from chickens and was present in poultry meat in every year of the study. Enteritidis pattern JEGX01.0004 (JEGX01.0003ARS) was associated with susceptibility to all antimicrobial agents tested in 94.7% of human and 97.2% of food animal Salmonella isolates. In contrast, multidrug resistance (resistance to three or more classes of antimicrobial agents) was observed in five PFGE patterns. Typhimurium patterns JPXX01.0003 (JPXX01.0003 ARS) and JPXX01.0018 (JPXX01.0002 ARS), considered together, were associated with resistance to five or more classes of antimicrobial agents: ampicillin, chloramphenicol, streptomycin, sulfonamides and tetracycline (ACSSuT), in 92% of human and 80% of food animal Salmonella isolates. The information from our study can assist in source attribution, outbreak investigations, and tailoring of interventions to maximize their impact on prevention.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24204990 PMCID: PMC3813714 DOI: 10.1371/journal.pone.0077836
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Food Animal Sources of Salmonella Recovered at Federally Inspected Slaughter and Processing Facilities in the Northeastern U.S.1 with Human Isolates Shown for Reference.
| Year | No. Chickens Tested | No. (%) Chickens Positive for | No. Cattle Tested | No. (%) Cattle Positive for | No. Turkeys Tested | No. (%)TurkeysPositive forSalmonella | No. Swine Tested | No. (%) Swine Positive for | Total No. Samples Inspected | Total No. (%) Positive for | No. Human Salmonella Received | No. 20 Most Common Human |
| 2005 | 1714 | 315 (18.4) | 9,754 | 102 (1.0) | 175 | 39 (22.3) | 2,191 | 61 (2.8) | 13,834 | 517 (3.7) | 1,537 | 549 |
| 2006 | 1,947 | 271 (13.9) | 8,449 | 117 (1.4) | 730 | 74 (10.1) | 2,346 | 78 (3.3) | 13,472 | 540 (4.0) | 1,686 | 749 |
| 2007 | 1,684 | 172 (10.2) | 6,539 | 76 (1.2) | 709 | 49 (6.9) | 1,643 | 27 (1.6) | 10,575 | 324 (3.1) | 1,829 | 706 |
| 2008 | 1,002 | 103 (10.3) | 6,241 | 90 (1.4) | 276 | 43 (15.6) | 1,342 | 26 (1.9) | 8,861 | 262 (3.0) | 1,680 | 645 |
| 2009 | 989 | 95 (9.6) | 4,005 | 19 (0.5) | 376 | 29 (7.7) | 1,099 | 13 (1.2) | 6,469 | 156 (2.4) | 1,706 | 662 |
| 2010 | 1,254 | 146 (11.6) | 3,099 | 29 (0.9) | 573 | 38 (6.6) | 1,137 | 24 (2.1) | 6,063 | 237 (3.9) | 1,749 | 716 |
| 2011 | 1,071 | 92 (8.6) | 4,281 | 39 (0.9) | 375 | 10 (2.7) | 654 | 10 (1.5) | 6,381 | 151 (2.4) | 1,778 | 695 |
| TOTAL | 9,661 | 1,194 (12.4) | 42,368 | 472 (1.1) | 3,214 | 282 (8.8) | 10,412 | 239 (2.3) | 65,655 | 2,187 (3.3) | 11,967 | 4722 |
Pennsylvania, Maine, Vermont, New Hampshire, New York, Maryland, Connecticut, Rhode Island, Massachusetts, Delaware, New Jersey, Indiana, Ohio, Michigan and Washington, DC.
Figure 1DNA fingerprints of the 20 most common human Salmonella patterns.
PFGE was conducted as described in Materials and Methods, with restriction endonucleases XbaI and BlnI. BlnI patterns represented at least three times in the dataset are shown.
Pennsylvania’s Most Common Human Salmonella PFGE Patterns Also Found in Salmonella Recovered from Food Animals Processed in the Northeastern U.S.
| Serotype | PulseNet XbaI Pattern | No. (% of All Human | No.Linked toOutbreaks | No. from Blood | % from Blood within Pattern | Association ofPFGE Pattern withBlood | CorrespondingVetNet Pattern | No. (%) | No.fromCattle | No.fromChicken | No.fromSwine | No.fromTurkey | |
| Berta | JAXX01.0001 | 49 (0.41) | 0 | 5 | 10.20 | 2.00 (0.70-4.75); 0.17 | JAXX01.0003 ARS | 3 (0.14) | 0 | 0 | 0 | 3 | |
| Enteritidis | JEGX01.0002 | 235 (1.96) | 3 | 14 | 5.96 | 1.11 (0.62-1.87); 0.68 | JEGX01.0017 ARS | 0 | 0 | 0 | 0 | 0 | |
| Enteritidis | JEGX01.0004 | 1,968 (16.45) | 79 | 130 | 6.61 | 1.30 (1.06-1.58); 0.01 | JEGX01.0003 ARS | 106 (5.09) | 1 | 105 | 0 | 0 | |
| Enteritidis | JEGX01.0005 | 426 (3.56) | 12 | 35 | 8.22 | 1.60 (1.11-2.26); 0.01 | JEGX01.0002 ARS | 65 (3.12) | 1 | 64 | 0 | 0 | |
| Enteritidis | JEGX01.0009 | 144 (1.20) | 1 | 15 | 10.42 | 2.06 (1.16-3.46); 0.02 | JEGX01.0022 ARS | 0 | 0 | 0 | 0 | 0 | |
| Enteritidis | JEGX01.0021 | 331 (2.77) | 24 | 21 | 6.34 | 1.19 (0.74-1.84); 0.43 | JEGX01.0010 ARS; JEGX01.0052 ARS | 1 (0.05) | 0 | 1 | 0 | 0 | |
| Enteritidis | JEGX01.0034 | 176 (1.47) | 11 | 1 | 0.57 | 0.10 (0.00-0.49); 0.00 | JEGX01.0005 ARS | 14 (0.67) | 0 | 14 | 0 | 0 | |
| Heidelberg | JF6X01.0022 | 151 (1.26) | 18 | 16 | 10.60 | 2.10 (1.21-3.48); 0.01 | JF6X01.0015 ARS | 30 (1.44) | 3 | 25 | 0 | 2 | |
| Newport | JJPX01.0011 | 54 (0.45) | 0 | 0 | 0 | 0.00 (0.00-1.00); 0.05 | JJPX01.0204 ARS | 1 (0.05) | 0 | 1 | 0 | 0 | |
| Newport | JJPX01.0061 | 72 (0.60) | 28 | 0 | 0 | 0.00 (0.00-0.74); 0.02 | JJPX01.0069 ARS | 1 (0.05) | 0 | 0 | 1 | 0 | |
| Thompson | JP6X01.0001 | 54 (0.45) | 0 | 3 | 5.56 | 1.03 (0.25-2.95); 0.90 | JP6X01.0024 ARS | 1 (0.05) | 0 | 1 | 0 | 0 | |
| Typhimurium | JPXX01.0001 | 53 (0.44) | 2 | 3 | 5.66 | 1.05 (0.26-3.02); 0.87 | JPXX01.0021 ARS | 1 (0.05) | 0 | 1 | 0 | 0 | |
| Typhimurium | JPXX01.0003 | 113 (0.94) | 2 | 9 | 7.96 | 1.52 (0.72-2.91); 0.24 | JPXX01.0003 ARS | 18 (0.86) | 6 | 5 | 3 | 4 | |
| Typhimurium | JPXX01.0018 | 81 (0.68) | 0 | 2 | 2.47 | 0.44 (0.07-1.51); 0.24 | JPXX01.0002 ARS | 2 (0.10) | 1 | 0 | 1 | 0 | |
| Typhimurium | JPXX01.0146 | 278 (2.32) | 16 | 1 | 0.36 | 0.06 (0.00-0.31); 0.00 | JPXX01.0081 ARS | 5 (0.24) | 0 | 1 | 4 | 0 | |
| Typhimurium | JPXX01.0302 | 149 (1.25) | 46 | 3 | 2.01 | 0.36 (0.09-0.99); 0.05 | JPXX01.0106 ARS | 2 (0.10) | 1 | 1 | 0 | 0 | |
| Typhimurium | JPXX01.0604 | 61 (0.51) | 3 | 1 | 1.64 | 0.29 (0.01-1.49); 0.18 | JPXX01.0079 ARS | 10 (0.48) | 1 | 7 | 0 | 2 | |
| Typhimurium;I 4, | JPXX01.0026 | 61 (0.51) | 4 | 1 | 1.64 | 0.29 (0.01-1.49); 0.18 | JPXX01.0308 ARS; TERX01.0010 ARS | 0 | 0 | 0 | 0 | 0 | |
| I 4, | JPXX01.0621 | 219 (1.83) | 2 | 8 | 3.65 | 0.66 (0.30-1.28); 0.25 | TERX01.0001 ARS | 15 (0.72) | 2 | 12 | 1 | 0 | |
| Typhimurium;I 4, | JPXX01.1212 | 47 (0.39) | 0 | 3 | 6.38 | 1.20 (0.29-3.45); 0.72 | JPXX01.0304 ARS; TERX01.0008 ARS | 0 | 0 | 0 | 0 | 0 | |
| TOTAL | 4,722 (39.46) | 251 | 271 | NA | TOTAL | 275 (13.20) | 16 | 238 | 10 | 11 | |||
Pattern names include a three-letter code that indicates serotype (e.g., JEG for serotype Enteritidis in the pattern names JEGX01.0004 and JEGA26.0002), followed by a three-character code for.
restriction enzyme (e.g., X01 for XbaI in JEGX01.0004; A26 for BlnI in JEGA26.0002), and a four-digit number for the unique strain designation (e.g., 0004 in JEGX01.0004) (Gerner-Smidt et al., 2006).
Percentage of total number of human Salmonella isolates (11,967).
Number of human Salmonella isolates recovered from blood for a particular pattern expressed as a percentage of the total number from all sources for that PFGE pattern; e.g., for Berta XbaI.
pattern JAXX01.0001, (5/49)×100 = 10.20%. Statistical method for determining Odds Ratio is described in Materials and Methods.
VetNet’s pattern nomenclature conforms to PulseNet’s nomenclature, with three exceptions: (1) PulseNet uses a single three-letter code (JPX) to designate both serotype Typhimurium and antigenic formula I 4,[5],12:i:- whereas VetNet uses two different codes, JPX for Typhimurium and TER for I 4,[5],12:i:-; (2) the four-digit strain designation codes are different in the two systems; and (3) “ARS” (for Agricultural Research Service of the USDA) is appended to VetNet pattern names.
Percentage of the total number of animal Salmonella isolates (2,083).
VetNet identified two different patterns within PulseNet pattern JEGX01.0021.
Antimicrobial resistance associated with the 16 most common human Salmonella PFGE patterns shared by food animal Salmonella.
| Human | Food Animal | |||||||||||||||
| Serotype | PulseNetXbaI Pattern | No.Tested | No. (%)Pansusceptible | No. (%) | No. (%) | No. (%) | No.Resist-antto Nal | No.Resist-antto Axo | CorrespondingVetNet-XbaI-pattern | No.Tested | No. (%)Pansusceptible | No. (%) | No. (%) | No. (%) | No.Resist-antto Nal | No.Resist-antto Axo |
| Berta | JAXX01.0001 | 16 | 9 (56.3) | 2 (12.5) | 5 (31.3) | 1 (6.3) | 1 | 2 | JAXX01.0003 ARS | 3 | 0 (0.0) | 0 (0.0) | 3 (100.0) | 0 (0.0) | 0 | 1 |
| Enteritidis | JEGX01.0004 | 114 | 108 (94.7) | 5 (4.4) | 1 (0.9) | 0 (0.0) | 1 | 0 | JEGX01.0003 ARS | 106 | 103 (97.2) | 3 (2.8) | 0 (0.0) | 0 (0.0) | 0 | 0 |
| Enteritidis | JEGX01.0005 | 25 | 25 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 | 0 | JEGX01.0002 ARS | 65 | 65 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 | 0 |
| Enteritidis | JEGX01.0021 | 33 | 27 (81.8) | 6 (7.3) | 0 (0.0) | 0 (0.0) | 0 | 0 | JEGX01.0010 ARS JEGX01.0052 ARS | 1 | 0 (0.0) | 1 (100.0) | 0 (0.0) | 0 (0.0) | 0 | 0 |
| Enteritidis | JEGX01.0034 | 22 | 21 (95.5) | 1 (4.5) | 0 (0.0) | 0 (0.0) | 0 | 0 | JEGX01.0005 ARS | 14 | 12 (85.7) | 2 (14.3) | 0 (0.0) | 0 (0.0) | 0 | 0 |
| Heidelberg | JF6X01.0022 | 14 | 13 (92.9) | 0 (0.0) | 1 (7.1) | 0 (00.) | 0 | 1 | JF6X01.0015 ARS | 30 | 18 (60.0) | 2 (6.7) | 10 (33.3) | 0 (0.0) | 0 | 10 |
| Newport | JJPX01.0011 | 9 | 9 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 | 0 | JJPX01.0204 ARS | 1 | 1 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 | 0 |
| Newport | JJPX01.0061 | 13 | 13 (100.0) | 0 (0.0) | 0 (0.0) | 0 (00.) | 0 | 0 | JJPX01.0069 ARS | 1 | 1 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 | 0 |
| Thompson | JP6X01.0001 | 8 | 8 (100) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 | 0 | JP6X01.0024 ARS | 1 | 1 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 | 0 |
| Typhimurium | JPXX01.0001 | 13 | 10 (76.9) | 1 (7.7) | 2 (15.4) | 1 (7.7) | 0 | 1 | JPXX01.0021 ARS | 1 | 1 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 | 0 |
| Typhimurium | JPXX01.0003 | 38 | 0 (0.0) | 1 (2.6) | 37 (97.4) | 37 (97.4) | 0 | 0 | JPXX01.0003 ARS | 18 | 0 (0.0) | 1 (5.6) | 17 (94.4) | 14 (78.0) | 0 | 0 |
| Typhimurium | JPXX01.0018 | 27 | 0 (0.0) | 2 (7.4) | 25 (92.6) | 23 (85.2) | 0 | 0 | JPXX01.0002 ARS | 2 | 0 (0.0) | 0 (0.0) | 2 (100.0) | 2 (100.0) | 0 | 0 |
| Typhimurium | JPXX01.0146 | 24 | 23 (95.8) | 1 (4.2) | 0 (0.0) | 0 (0.0) | 0 | 0 | JPXX01.0081 ARS | 5 | 5 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 | 0 |
| Typhimurium | JPXX01.0302 | 22 | 20 (90.9) | 1 (4.5) | 1 (4.5) | 0 (0.0) | 1 | 0 | JPXX01.0106 ARS | 2 | 2 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 | 0 |
| Typhimurium | JPXX01.0604 | 13 | 13 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 | 0 | JPXX01.0079 ARS | 10 | 10 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 | 0 |
| I 4, | JPXX01.0621 | 76 | 68 (89.5) | 5 (6.6) | 3 (3.9) | 0 (0.0) | 0 | 1 | TERX01.0001 ARS | 15 | 7 (46.7) | 0 (0.0) | 8 (53.3) | 0 (0.0) | 0 | 7 |
| TOTAL | 467 | 367 (78.6) | 25 (5.4) | 75 (16.1) | 62 (13.3) | 3 | 5 | TOTAL | 275 | 226 (82.2) | 9 (3.3) | 40 (14.5) | 16 (5.8) | 0 | 18 | |
Typhimurium includes var. O5-.
Resistant to at least three classes of antimicrobial agents.
Abbreviations: nalidixic acid (Nal); ceftriaxone (Axo).
VetNet identified two different patterns within PulseNet pattern JEGX01.0021.
Based on 467 isolates tested for antimicrobial susceptibility.
Based on 275 isolates tested for antimicrobial susceptibility.
Antimicrobial classes (antimicrobial agents in parentheses; resistance breakpoints in brackets): aminoglycosides (amikacin [≥64 µg/mL], gentamicin [≥16 µg/mL], kanamycin [≥64 µg/mL] and streptomycin [≥64 µg/mL]), ß-lactam/ß-lactamase inhibitor combinations (amoxicillin/clavulanic acid [≥32/16 µg/mL]), cephems (cefoxitin [≥32 µg/mL], ceftiofur [≥8 µg/mL] and ceftriaxone [≥4 µg/mL]), penicillins (ampicillin [≥32 µg/mL]), quinolones (ciprofloxacin [≥4 µg/mL]and nalidixic acid [≥32 µg/mL]), folate pathway inhibitors (sulfisoxazole [≥512 µg/mL], trimethoprim/sulfamethoxazole [≥4/76 µg/mL]), phenicols (chloramphenicol [≥32 µg/mL]), and tetracyclines (tetracycline [≥16 µg/mL]).